Objective To evaluate and compare cancer detection rates (CDRs) of transition zone (TZ) lesions upgraded from PI-RADSv2.1 score 2 to 3 (“2 + 1”) or from 3 to 4 (“3 + 1”) using DWI and assess their clinical impact. Materials and methods A systematic literature search was performed in Embase, Medline, and Web of Science for studies assessing TZ lesions with DWI in PI-RADSv2.1, with histology-confirmed grade group ≥ 2 cancer (GG ≥ 2) as the primary outcome. Risk of bias was evaluated using QUADAS-2. Pooled sensitivity, specificity, CDRs, and odds ratios (ORs) were estimated at the lesion level using a bivariate binomial random-effects model. Results Eight studies with 1535 TZ lesions were included. GG ≥ 2 CDRs for PI-RADS scores of 1, 2, 2 + 1, 3, 3 + 1, 4, and 5 were 2% (95%CI: 0%–12%), 6% (4%–10%), 13% (6%–23%), 19% (15%–25%), 37% (24%–52%), 49% (32%–67%), and 73% (66%–79%), respectively. Scores of 2 + 1 had higher GG ≥ 2 CDRs than 2 (OR 3.37 (1.53–7.44), p = 0.003) but were similar to 3 (OR 0.80 (0.44–1.45), p = 0.46). Scores of 3 + 1 had higher GG ≥ 2 CDRs than 3 (OR 2.67 (1.27–5.59), p = 0.009) but were similar to 4 (OR 0.68 (0.33–1.44), p = 0.32). False-positive rates remained substantial (≥ 2 + 1: 69% (55%–80%); ≥ 3: 54% (46%–62%)). Conclusion The risk of having significant prostate cancer in “2 + 1” and “3 + 1” TZ lesions, with an upgrading based on DWI images, is appropriately categorized within the PI-RADS v2.1 scoring system, as shown by this meta-analysis. Key Points <Emphasis Type="BoldItalic">Question</Emphasis> PI-RADS v2.1 incorporates rules allowing scores of some transition zone (TZ) lesions to be increased. Literature on the clinical impact of these rules is scarce. <Emphasis Type="BoldItalic">Findings</Emphasis> For TZ lesions upgraded with DWI: “2 + 1” lesions show a cancer detection rate (CDR) of 13%, and “3 + 1” lesions show a CDR of 37%. <Emphasis Type="BoldItalic">Clinical relevance</Emphasis> Upgraded TZ lesions may impact individualized biopsy-decisions, especially as “3 + 1” lesions harbor significant disease in 2-out-of-5 patients. Still, the high rate of grade group = 1 and benign findings in these sub-categories emphasizes the need for strategies to minimize overdiagnosis. Graphical Abstract

Detection rates for prostate cancer using PI-RADS 2.1 upgrading rules in transition zone lesions align with risk assessment categories: a systematic review and meta-analysis

期刊论文
出版模式：

开放获取
发表日期：

2025年4月27日

查看全文

Georgios Agrotis,
Eduardo Pais Pooch,
Kostas Marsitopoulos,
Marianna Vlychou,
Matthias Benndorf,
Regina G. H. Beets-Tan,
Ivo G. Schoots

摘要

Objective

To evaluate and compare cancer detection rates (CDRs) of transition zone (TZ) lesions upgraded from PI-RADSv2.1 score 2 to 3 (“2 + 1”) or from 3 to 4 (“3 + 1”) using DWI and assess their clinical impact.

Materials and methods

A systematic literature search was performed in Embase, Medline, and Web of Science for studies assessing TZ lesions with DWI in PI-RADSv2.1, with histology-confirmed grade group ≥ 2 cancer (GG ≥ 2) as the primary outcome. Risk of bias was evaluated using QUADAS-2. Pooled sensitivity, specificity, CDRs, and odds ratios (ORs) were estimated at the lesion level using a bivariate binomial random-effects model.

Results

Eight studies with 1535 TZ lesions were included. GG ≥ 2 CDRs for PI-RADS scores of 1, 2, 2 + 1, 3, 3 + 1, 4, and 5 were 2% (95%CI: 0%–12%), 6% (4%–10%), 13% (6%–23%), 19% (15%–25%), 37% (24%–52%), 49% (32%–67%), and 73% (66%–79%), respectively. Scores of 2 + 1 had higher GG ≥ 2 CDRs than 2 (OR 3.37 (1.53–7.44), p = 0.003) but were similar to 3 (OR 0.80 (0.44–1.45), p = 0.46). Scores of 3 + 1 had higher GG ≥ 2 CDRs than 3 (OR 2.67 (1.27–5.59), p = 0.009) but were similar to 4 (OR 0.68 (0.33–1.44), p = 0.32). False-positive rates remained substantial (≥ 2 + 1: 69% (55%–80%); ≥ 3: 54% (46%–62%)).

Conclusion

The risk of having significant prostate cancer in “2 + 1” and “3 + 1” TZ lesions, with an upgrading based on DWI images, is appropriately categorized within the PI-RADS v2.1 scoring system, as shown by this meta-analysis.

Key Points

Question PI-RADS v2.1 incorporates rules allowing scores of some transition zone (TZ) lesions to be increased. Literature on the clinical impact of these rules is scarce.

Findings For TZ lesions upgraded with DWI: “2 + 1” lesions show a cancer detection rate (CDR) of 13%, and “3 + 1” lesions show a CDR of 37%.

Clinical relevance Upgraded TZ lesions may impact individualized biopsy-decisions, especially as “3 + 1” lesions harbor significant disease in 2-out-of-5 patients. Still, the high rate of grade group = 1 and benign findings in these sub-categories emphasizes the need for strategies to minimize overdiagnosis.

Graphical Abstract